Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-26

Clinical Trial Update: Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Cerebrolysin for disorders of consciousness, including hemorrhagic stroke, with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cerebrolysin

Snippet

Sponsor: Konkuk University Medical Center | Conditions: Disorder of Consciousness, Hemorrhagic Stroke | Phase 4 | Status: UNKNOWN